March 11, 2010 — Valensa International (Eustis, FL USA) and UAS Laboratories (Eden Prairie, MN) announced they have entered into a license and supply agreement that provides UAS access to Valensa’s patented Cran-Gyn ingredient for use in a new, patent-pending “triple action” women’s health product called Cran-Gyn DDS.
Cran-Gyn DDS combines the known power of Lactobacillus acidophilus DDS probiotics with Cran-Gyn — a concentrated, proprietary cranberry/d-mannose formulation. Cran-Gyn DDS offers a low-calorie, natural alternative to women for the management of UTI issues and yeast health management as well as improvement of digestive health and immune function, in a low calorie easy-to-use dosage form with low “pill burden”. Cran-Gyn DDS will be introduced by UAS Laboratories, Inc. at the 2010 Natural Products Expo West in Anaheim, Calif. March 12 2010.
According to Dr. Rudi E. Moerck, President and CEO of Valensa, UAS Laboratories, Inc. is an excellent partner for Valensa in bringing its Cran-Gyn women’s triple action health technology to a broader market.
Source: UAS Laboratories, www.uaslabs.com
Related Posts
National Handwashing Awareness week: Why it matters to DCs- How to build a personal injury practice in 2023
- Bill aims to expand student loan relief for DCs serving in medically underserved areas
- First things first: Steps you can take now to ensure success in the event of an RAC audit
- ChiroNutraceutical receives Natural Health Product registration number
